Anna-maria M. Szczesniak
Halifax, NS B3H4R2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia In Vitro.
Journal: ACS pharmacology & translational science
Published: January 12, 2024
Topical analgesics for acute corneal pain: current options and emerging therapeutics.
Journal: Journal of cataract and refractive surgery
Published: October 14, 2022
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy.
Journal: Journal of medicinal chemistry
Published: April 07, 2021
Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators.
Journal: Journal of medicinal chemistry
Published: November 23, 2019
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.
Journal: Molecules (Basel, Switzerland)
Published: November 18, 2019
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
Journal: Molecules (Basel, Switzerland)
Published: August 05, 2019
DIBI, a polymeric hydroxypyridinone iron chelator, reduces ocular inflammation in local and systemic endotoxin-induced uveitis.
Journal: Clinical hemorheology and microcirculation
Published: April 10, 2018
Revisiting cannabinoid receptor 2 expression and function in murine retina.
Journal: Neuropharmacology
Published: April 06, 2018
The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation.
Journal: Cannabis and cannabinoid research
Published: February 17, 2018
Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye.
Journal: Prostaglandins & other lipid mediators
Published: February 12, 2018
The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: July 19, 2017
Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
Journal: Neuropharmacology
Published: February 07, 2016
Last Updated: 09/26/2026